Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prion diseases in men]

C Keohane1

  • 1Department of Pathology (Neuropathology), Cork Regional Hospital, Wilton, Eire.

Archives D'Anatomie Et De Cytologie Pathologiques
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Mad cow disease and Creutzfeldt-Jakob disease are progressive, untreatable dementing illnesses. These spongiform encephalopathies are caused by a novel infectious agent, the prion, raising public health concerns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the proceedings of the 20th annual meeting of the irish neurological association held on 25th-26th may, 1984.

Irish journal of medical science·2016
Same author

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

The New England journal of medicine·2013
Same author

The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.

Journal of neuro-oncology·2013
Same author

Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival.

Neuropathology and applied neurobiology·2011
Same author

Eccrine syringofibroadenoma of the eyelid in association with eye prosthesis.

Eye (London, England)·2011
Same author

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same journal

[Peritoneal pseudomyxoma associated with an ovarian and appendicular mucinous tumor].

Archives d'anatomie et de cytologie pathologiques·1999
Same journal

[Papillary fibroelastoma: a cardiac tumor rarely reported in children].

Archives d'anatomie et de cytologie pathologiques·1999
Same journal

[Extramembranous glomerulonephritis: clinicopathologic finding in a group of 45 Cameroonians].

Archives d'anatomie et de cytologie pathologiques·1999
Same journal

[Biotin-rich pseudoherpetic intranuclear inclusions. A diagnostic pitfall].

Archives d'anatomie et de cytologie pathologiques·1999
Same journal

[Primary gastric MALT lymphoma in children. Report of 2 cases].

Archives d'anatomie et de cytologie pathologiques·1999
Same journal

[Granular cell tumor and congenital epulis. Histochemical and immunohistochemical of 58 cases].

Archives d'anatomie et de cytologie pathologiques·1999
See all related articles

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biochemistry

Context:

  • Public concern over prion diseases like "mad cow disease" and iatrogenic Creutzfeldt-Jakob disease (iCJD).
  • Cases of iCJD linked to contaminated pituitary-derived growth hormone treatments.
  • Spongiform encephalopathies represent a unique class of neurodegenerative disorders.

Purpose:

  • To inform about the nature of prion diseases.
  • To highlight the unique causative agent, the prion.
  • To underscore the lack of effective treatments.

Summary:

  • Spongiform encephalopathies are progressive neurodegenerative diseases.
  • These conditions are caused by prions, a novel infectious agent.
  • No specific immune or inflammatory responses are observed in affected individuals.

Related Experiment Videos

Impact:

  • Increased public awareness and concern regarding prion diseases.
  • Highlights the need for further research into prion biology and disease mechanisms.
  • Emphasizes the current therapeutic challenges in managing these fatal neurological conditions.